Author: Walker Taylor IV
Gallagher's Summer 2024 Life Sciences Insurance Market Update complements Gallagher's March 2024 report of broader insurance market conditions. This supplement offers insights into what pharmaceutical, biotechnology, medical device, contract manufacturing organization (CMOs) and related companies are experiencing with insurance carriers.
The report explores a number of factors that are driving the risk transfer market, including general inflation, higher interest rates, capital market effects, regulatory impacts and social inflation.
This report looks at these coverages as they related to life sciences organizations:
- Directors and officers (D&O) liability
- Property
- Workers' compensation
- Cyber
- General liability Including products/clinical trials liability
- Auto liability